Vestibular destruction by slow infusion of gentamicin into semicircular canals

Acta Oto-Laryngologica, Supplement

Volumn 124, Issue 552, 2004, Pages 35-41

  Li, Ming ^a   Ding, Dalian ^b   Zheng, Xiang Yang ^b   Salvi, Richard ^b,c  

^a Yueyang Hosp Shanghai T   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Chinchilla; Gentamicin; Hair cells; Nystagmus; Osmotic pump; Otoacoustic emission; Vestibular system

Indexed keywords

GENTAMICIN; ANTIINFECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL DENSITY; CELL LOSS; CHINCHILLA; COCHLEA; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG EFFECT; DRUG INFUSION; DRUG MEGADOSE; DRUG RESPONSE; EVALUATION; HAIR CELL; HEARING LOSS; HYPOACUSIS; LOW DRUG DOSE; MEASUREMENT; NONHUMAN; NYSTAGMUS; OSMOTIC PUMP; PRIORITY JOURNAL; RISK REDUCTION; SACCULUS; SEMICIRCULAR CANAL; UTRICLE; VESTIBULAR DISORDER; VESTIBULAR SYSTEM; ANIMAL; ARTICLE; DOSE RESPONSE; INFUSION PUMP; MENIERE DISEASE; OPTOKINETIC NYSTAGMUS; PATHOPHYSIOLOGY; SPONTANEOUS OTOACOUSTIC EMISSION; VESTIBULE;

ANIMALS; ANTI-BACTERIAL AGENTS; CHINCHILLA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENTAMICINS; HAIR CELLS; HEARING LOSS; INFUSION PUMPS, IMPLANTABLE; MENIERE'S DISEASE; NYSTAGMUS, PHYSIOLOGIC; OTOACOUSTIC EMISSIONS, SPONTANEOUS; SEMICIRCULAR CANALS; VESTIBULE;

EID: 2942718780     PISSN: 03655237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Baloh RW. The dizzy patient. Postgrad Med 1999; 105: 161-4, 167-72.
2. Rosenberg SI. Vestibular surgery for Ménière's disease in the elderly: a review of techniques and indications. Ear Nose Throat J 1999; 78: 443-6.
3. Silverstein H, Arruda J, Rosenberg SI, Deems D, Hester TO. Direct round window membrane application of gentamicin in the treatment of Ménière's disease. Otolaryngol Head Neck Surg 1999; 120: 649-55.
4. Atlas JT, Parnes LS. Intratympanic gentamicin titration therapy for intractable Ménière's disease. Am J Otol 1999; 20: 357-63.
5. Blakley BW. Update on intratympanic gentamicin for Méniè re's disease. Laryngoscope 2000; 110: 236-40.
6. Silverstein H. Streptomycin treatment for Ménière's disease. Ann Otol Rhinol Laryngol Suppl 1984; 112: 44-8.
7. Odkvist L. Gentamicin cures vertigo, but what happens to hearing? Int Tinnitus J 1997; 3: 133-6.
8. Nedzelski JM, Bryce GE, Pfleiderer AG. Treatment of Méniè re's disease with topical gentamicin: a preliminary report. J Otolaryngol 1992; 21: 95-101.
9. Balough BJ, Hoffer ME, Wester D, O'Leary MJ, Brooker CR, Goto M. Kinetics of gentamicin uptake in the inner ear of Chinchilla langier after middle-ear administration in a sustained-release vehicle. Otolaryngol Head Neck Surg 1998; 119: 427-31.
10. DeCicco MJ, Hoffer ME, Kopke RD, et al. Round-window microcatheter- administered microdose gentamicin: results from treatment of tinnitus associated with Ménière's disease. Int Tinnitus J 1998; 4: 141-3.
11. Kuppers P, Ahrens H, Blessing R. Continuous intratympanic gentamycin infusion in Ménière disease. HNO 1994; 42: 429-33.
12. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Ménière's disease. Am J Otol 1998; 19: 435-42.
13. McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ. Intratympanic gentamicin treatment for Ménière's disease. Otolaryngol Head Neck Surg 1998; 118: 589-96.
14. Mondain M, Mouchet F, Marlier F, Makeieff M, Biboulet R, Uziel A. Chemical labyrinthectomy: results and applications. Ann Otolaryngol Chir Cervicofac 1998; 115: 234-42.
15. Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Ménière's disease: results of therapy. Am J Otol 1997; 18: 52-7.
16. Wang J, Ding D, Shulman A, Stracher A, Salvi RJ. Leupeptin protects sensory hair cells from acoustic trauma. Neuroreport 1999; 10: 811-6.
17. Hofstetter P, Ding D, Powers N, Salvi RJ. Quantitative relationship of carboplatin dose to magnitude of inner and outer hair cell loss and the reduction in distortion product otoacoustic emission amplitude in chinchillas. Hear Res 1997; 112: 199-215.
18. Ding D, Wang J, Salvi RJ. Early damage in the chinchilla vestibular sensory epithelium from carboplatin. Audiol Neurootol 1997; 2: 155-67.
19. Ding DL, McFadden SL, Wang J, Hu BH, Salvi RJ. Age- and strain-related differences in dehydrogenase activity and glycogen levels in CBA and C57 mouse cochleas. Audiol Neurootol 1999; 4: 55-63.
20. Greenwood DD. A cochlear frequency-position function for several species - 29 years later. J Acoust Soc Am 1990; 87: 2592-604.
21. Odkvist LM, Bergenius J, Moller C. When and how to use gentamicin in the treatment of Ménière's disease. Acta Otolaryngol Suppl 1997; 526: 54-7.
22. Hoffer ME, Balough B, Henderson J, et al. Use of sustained release vehicles in the treatment of Ménière's disease. Otolaryngol Clin North Am 1997; 30: 1159-66.
23. Brown AM, McDowell B, Forge A. Acoustic distortion products can be used to monitor the effects of chronic gentamicin treatment. Hear Res 1989; 42: 143-56.
24. O'Neill G. The caloric stimulus. Temperature generation within the temporal bone. Acta Otolaryngol 1987; 103: 266-72.
25. Baloh RW, Honrubia V, editors. Clinical neurophysiology of the vestibular system. New York: Oxford University Press, 2001.